EPS for Wright Medical Group N.V. (WMGI) Expected At $-0.06; Mufg Americas Holdings Lowered Constellation Brands (STZ) Stake

April 17, 2018 - By Richard Conner

Wright Medical Group N.V. (NASDAQ:WMGI) Logo

Analysts expect Wright Medical Group N.V. (NASDAQ:WMGI) to report $-0.06 EPS on May, 9 after the close.They anticipate $0.03 EPS change or 33.33% from last quarter’s $-0.09 EPS. After having $0.10 EPS previously, Wright Medical Group N.V.’s analysts see -160.00% EPS growth. The stock decreased 1.75% or $0.36 during the last trading session, reaching $20.24. About 407,478 shares traded. Wright Medical Group N.V. (NASDAQ:WMGI) has declined 36.24% since April 17, 2017 and is downtrending. It has underperformed by 47.79% the S&P500.

Mufg Americas Holdings Corp decreased Constellation Brands Inc (STZ) stake by 4.15% reported in 2017Q4 SEC filing. Mufg Americas Holdings Corp sold 2,640 shares as Constellation Brands Inc (STZ)’s stock declined 2.39%. The Mufg Americas Holdings Corp holds 60,912 shares with $13.92M value, down from 63,552 last quarter. Constellation Brands Inc now has $45.02 billion valuation. The stock increased 1.78% or $4.04 during the last trading session, reaching $231.06. About 737,517 shares traded. Constellation Brands, Inc. (NYSE:STZ) has risen 33.47% since April 17, 2017 and is uptrending. It has outperformed by 21.92% the S&P500.

Wright Medical Group N.V., a medical device company, designs, makes, markets, and sells extremities and biologics products.in the United States, Europe, the Middle East, Africa, and internationally. The company has market cap of $2.14 billion. The firm offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It currently has negative earnings. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries.

Among 19 analysts covering Wright Medical Group (NASDAQ:WMGI), 15 have Buy rating, 0 Sell and 4 Hold. Therefore 79% are positive. Wright Medical Group had 44 analyst reports since August 20, 2015 according to SRatingsIntel. Northcoast upgraded the stock to “Buy” rating in Tuesday, March 21 report. Needham downgraded Wright Medical Group N.V. (NASDAQ:WMGI) on Wednesday, February 15 to “Hold” rating. As per Thursday, September 3, the company rating was maintained by Needham. Cantor Fitzgerald maintained it with “Buy” rating and $30.0 target in Monday, January 8 report. On Wednesday, August 2 the stock rating was maintained by Piper Jaffray with “Buy”. Bank of America downgraded the shares of WMGI in report on Tuesday, April 11 to “Neutral” rating. BMO Capital Markets maintained Wright Medical Group N.V. (NASDAQ:WMGI) rating on Thursday, November 2. BMO Capital Markets has “Outperform” rating and $31 target. The firm earned “Hold” rating on Wednesday, September 2 by Piper Jaffray. Bank of America initiated the shares of WMGI in report on Monday, April 11 with “Buy” rating. Robert W. Baird maintained Wright Medical Group N.V. (NASDAQ:WMGI) rating on Wednesday, February 28. Robert W. Baird has “Buy” rating and $28.0 target.

Among 23 analysts covering Constellation Brands (NYSE:STZ), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Constellation Brands had 83 analyst reports since August 27, 2015 according to SRatingsIntel. The firm has “Buy” rating by RBC Capital Markets given on Thursday, December 21. On Friday, June 9 the stock rating was maintained by Morgan Stanley with “Buy”. The firm earned “Outperform” rating on Tuesday, April 5 by Wells Fargo. RBC Capital Markets maintained the stock with “Outperform” rating in Wednesday, December 16 report. The stock of Constellation Brands, Inc. (NYSE:STZ) has “Outperform” rating given on Thursday, October 8 by RBC Capital Markets. The rating was maintained by RBC Capital Markets with “Buy” on Monday, April 2. Morgan Stanley maintained the shares of STZ in report on Tuesday, April 3 with “Overweight” rating. The firm has “Buy” rating given on Monday, September 18 by Stifel Nicolaus. The firm earned “Buy” rating on Friday, November 10 by RBC Capital Markets. RBC Capital Markets maintained Constellation Brands, Inc. (NYSE:STZ) on Tuesday, August 1 with “Buy” rating.

Since January 30, 2018, it had 0 buys, and 3 selling transactions for $5.22 million activity. 17,900 shares valued at $4.09M were sold by Klein David Eric on Monday, April 2. $441,943 worth of Constellation Brands, Inc. (NYSE:STZ) was sold by FROMBERG BARRY A.

Investors sentiment increased to 1.24 in 2017 Q4. Its up 0.10, from 1.14 in 2017Q3. It is positive, as 43 investors sold STZ shares while 243 reduced holdings. 97 funds opened positions while 257 raised stakes. 140.30 million shares or 2.61% less from 144.05 million shares in 2017Q3 were reported. Aqr Cap Management Ltd Llc accumulated 718,826 shares. Moreover, Jfs Wealth Advsr Ltd Llc has 0% invested in Constellation Brands, Inc. (NYSE:STZ) for 13 shares. Karpus Incorporated has 4,240 shares for 0.04% of their portfolio. Peddock Capital Advsrs Ltd Liability Company invested in 2.48% or 21,622 shares. Efg Asset Mgmt (Americas) has 0.64% invested in Constellation Brands, Inc. (NYSE:STZ). Connor Clark & Lunn Invest Mngmt Limited reported 0% in Constellation Brands, Inc. (NYSE:STZ). First Allied Advisory stated it has 3,743 shares or 0.03% of all its holdings. Hartford Inv Mngmt holds 0.15% or 35,416 shares. Chicago Equity Partners Ltd Liability Company owns 6,575 shares or 0.05% of their US portfolio. Amalgamated State Bank invested in 21,546 shares. Bp Public Ltd Liability Co reported 34,000 shares. Tributary Mgmt Ltd Co holds 0.06% or 2,900 shares. Natixis has invested 0.06% of its portfolio in Constellation Brands, Inc. (NYSE:STZ). Two Sigma Securities Limited Liability Com reported 0.02% stake. Concorde Asset Ltd Liability Company owns 2,126 shares or 0.62% of their US portfolio.

Constellation Brands, Inc. (NYSE:STZ) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Posts